Purchase Order HHSN275201600839P

Award Date 8/1/16
Potential Completion Date 7/31/17
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92126, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for a peptide synthesis facility to conduct storage and stability studies of drug substances and products. Polypeptide Laboratories San Diego, LLC will perform the requested studies at its location in San Diego, California over a six-month period from February 1, 2016...
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), has awarded a $17,950 firm fixed-price purchase order to Polypeptide Laboratories San Diego, LLC (Polypeptide Labs) for a storage and stability study of drug substances and products. This contract, which has an ultimate completion date of July 31, 2025, does not have a set-aside designation. Polypeptide Labs is a specialized manufacturer of peptides and related compounds,...
Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the National Institutes of Health's National Institute on Drug Abuse. The $598,190 delivery order is for the synthesis and distribution of opioid and related peptides over the one year period of performance from February 15, 2024 through February 14, 2025. The underlying indefinite delivery contract, awarded in 2022...
This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs. The 5-year, $4,999,491.97 contract is for the synthesis and distribution of opioid and related peptides. It is a cost-plus-fixed-fee definitive contract that was awarded on February 15, 2017 and runs through February 14, 2022, with a current ultimate completion date of July 16,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,000 purchase order to Genscript USA Inc. to deliver a 2000 base pair gene synthesis in a PUC57 vector with 4 micrograms of the synthesized gene. The place of performance for this firm fixed price contract is in Bethesda, Maryland. This purchase supports the NIH's mission to conduct and fund medical research that could improve public health, likely...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $4,580 purchase order contract to Genscript USA Inc. to provide customized protein services. The contract has a firm fixed price and will be performed in Bethesda, Maryland over a five-month period concluding in April 2017. No set-aside designation or subcontractors were indicated. The National Institute of Child Health and Human Development conducts...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,595 firm fixed price purchase order to Cyprotex US LLC for testing services. The place of performance is Bethesda, Maryland. The period of performance is from September 8, 2017 through March 7, 2018. No set aside designation or major subcontractors were indicated. The National Institute of Child Health and Human Development supports research on...
This is a firm-fixed-price purchase order awarded to Vivitide LLC, doing business as New England Peptide, by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The $26,440.00 award is for the procurement of 2x NEP Monoclonal Antibody Packages. This purchase order was issued without a set-aside and has a completion date of March 21, 2021. The original solicitation was a special notice indicating NICHD's...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $45,500 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, for PROTEINSIMPLE:1156002. The place of performance is San Jose, California. The period of performance is September 14, 2018 through September 16, 2019. No subcontractors or set aside designations were identified. The National...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...

The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $23,000 firm fixed price purchase order to Polypeptide Laboratories San Diego, LLC for a peptide synthesis facility to conduct storage and stability studies of drug substances and products. As the prime contractor, Polypeptide Labs will perform the requested studies at its location in San Diego, California over a one year period from August 1, 2016 through July 31, 2017. No subcontractors or set aside designations were identified. The award provides targeted support for the National Institute of Child Health and Human Development's research efforts to evaluate peptide-based drug candidates in its programs.

Generated 12/30/23, 9:06 AM